Hyperbaric oxygen therapy in chronic stable multiple sclerosis: double-blind study. 1986

G D Harpur, and R Suke, and B H Bass, and M J Bass, and S B Bull, and L Reese, and J H Noseworthy, and G P Rice, and G C Ebers

We carried out a randomized, double-blind, placebo-controlled trial of hyperbaric oxygen therapy (HBO) in patients with chronic stable MS. Eighty-two patients were treated in a multiplace hyperbaric chamber with gas supplied by mask. Forty-one patients received 20 consecutive daily treatments of 100% O2 followed by 7 "booster" treatments in the next 6 months; 41 control patients received "air" (12.5% O2 at 1.75 atmospheres absolute). There was no significant difference in treatment and control groups in the Extended Kurtzke Disability scores, Kurtzke Functional scores, magnetic resonance imaging, or evoked potentials after the initial 20 treatments or after the boosters. HBO is not effective in treating chronic stable MS.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005072 Evoked Potentials, Auditory The electric response evoked in the CEREBRAL CORTEX by ACOUSTIC STIMULATION or stimulation of the AUDITORY PATHWAYS. Auditory Evoked Potentials,Auditory Evoked Response,Auditory Evoked Potential,Auditory Evoked Responses,Evoked Potential, Auditory,Evoked Response, Auditory,Evoked Responses, Auditory,Potentials, Auditory Evoked
D005074 Evoked Potentials, Visual The electric response evoked in the cerebral cortex by visual stimulation or stimulation of the visual pathways. Visual Evoked Response,Evoked Potential, Visual,Evoked Response, Visual,Evoked Responses, Visual,Potential, Visual Evoked,Potentials, Visual Evoked,Response, Visual Evoked,Responses, Visual Evoked,Visual Evoked Potential,Visual Evoked Potentials,Visual Evoked Responses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

G D Harpur, and R Suke, and B H Bass, and M J Bass, and S B Bull, and L Reese, and J H Noseworthy, and G P Rice, and G C Ebers
February 1986, British medical journal (Clinical research ed.),
G D Harpur, and R Suke, and B H Bass, and M J Bass, and S B Bull, and L Reese, and J H Noseworthy, and G P Rice, and G C Ebers
September 1986, Presse medicale (Paris, France : 1983),
G D Harpur, and R Suke, and B H Bass, and M J Bass, and S B Bull, and L Reese, and J H Noseworthy, and G P Rice, and G C Ebers
January 1986, Revue neurologique,
G D Harpur, and R Suke, and B H Bass, and M J Bass, and S B Bull, and L Reese, and J H Noseworthy, and G P Rice, and G C Ebers
January 1983, The New England journal of medicine,
G D Harpur, and R Suke, and B H Bass, and M J Bass, and S B Bull, and L Reese, and J H Noseworthy, and G P Rice, and G C Ebers
June 1986, British journal of hospital medicine,
G D Harpur, and R Suke, and B H Bass, and M J Bass, and S B Bull, and L Reese, and J H Noseworthy, and G P Rice, and G C Ebers
June 1986, Acta neurologica Scandinavica,
G D Harpur, and R Suke, and B H Bass, and M J Bass, and S B Bull, and L Reese, and J H Noseworthy, and G P Rice, and G C Ebers
September 1985, The Medical journal of Australia,
G D Harpur, and R Suke, and B H Bass, and M J Bass, and S B Bull, and L Reese, and J H Noseworthy, and G P Rice, and G C Ebers
January 2002, Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc,
G D Harpur, and R Suke, and B H Bass, and M J Bass, and S B Bull, and L Reese, and J H Noseworthy, and G P Rice, and G C Ebers
March 1986, The Journal of the Association of Physicians of India,
G D Harpur, and R Suke, and B H Bass, and M J Bass, and S B Bull, and L Reese, and J H Noseworthy, and G P Rice, and G C Ebers
January 2004, The Cochrane database of systematic reviews,
Copied contents to your clipboard!